These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 12114489)

  • 1. Concerns of women presenting to a comprehensive cancer centre for genetic cancer risk assessment.
    MacDonald DJ; Choi J; Ferrell B; Sand S; McCaffrey S; Blazer KR; Grant M; Weitzel JN
    J Med Genet; 2002 Jul; 39(7):526-30. PubMed ID: 12114489
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of psychosocial effects of pre-symptomatic testing for breast/ovarian and colon cancer pre-disposing genes: a 12-month follow-up.
    Arver B; Haegermark A; Platten U; Lindblom A; Brandberg Y
    Fam Cancer; 2004; 3(2):109-16. PubMed ID: 15340261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of psychological factors associated with genetic testing for hereditary breast, ovarian and colon cancers.
    Vadaparampil ST; Ropka M; Stefanek ME
    Fam Cancer; 2005; 4(2):195-206. PubMed ID: 15951974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A model protocol for evaluating the behavioral and psychosocial effects of BRCA1 testing.
    Botkin JR; Croyle RT; Smith KR; Baty BJ; Lerman C; Goldgar DE; Ward JM; Flick BJ; Nash JE
    J Natl Cancer Inst; 1996 Jul; 88(13):872-82. PubMed ID: 8656439
    [No Abstract]   [Full Text] [Related]  

  • 5. Scale-up technology: moving predictive tests for inherited breast, ovarian, and colon cancers from the bench to the bedside and beyond.
    Holtzman NA
    J Natl Cancer Inst Monogr; 1995; (17):95-7. PubMed ID: 8573464
    [No Abstract]   [Full Text] [Related]  

  • 6. The development of a cancer genetic-specific measure of coping: the GRACE.
    Phelps C; Bennett P; Jones H; Hood K; Brain K; Murray A
    Psychooncology; 2010 Aug; 19(8):847-54. PubMed ID: 19823974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of BRCA1 testing on women with cancer: a pilot study.
    Wood ME; Mullineaux L; Rahm AK; Fairclough D; Wenzel L
    Genet Test; 2000; 4(3):265-72. PubMed ID: 11142757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Permanence of the information given during oncogenetic counseling to persons at familial risk of breast/ovarian and/or colon cancer.
    Kwiatkowski F; Dessenne P; Laquet C; Petit MF; Bignon YJ
    Eur J Hum Genet; 2012 Feb; 20(2):141-7. PubMed ID: 21934710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence patterns to National Comprehensive Cancer Network (NCCN) guidelines for referral to cancer genetic professionals.
    Febbraro T; Robison K; Wilbur JS; Laprise J; Bregar A; Lopes V; Legare R; Stuckey A
    Gynecol Oncol; 2015 Jul; 138(1):109-14. PubMed ID: 25933682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does the diagnosis of breast or ovarian cancer trigger referral to genetic counseling?
    Powell CB; Littell R; Hoodfar E; Sinclair F; Pressman A
    Int J Gynecol Cancer; 2013 Mar; 23(3):431-6. PubMed ID: 23354368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic counseling, testing, and screening for breast and ovarian cancer: practical and social considerations.
    Khabele D; Runowicz CD
    Curr Womens Health Rep; 2002 Jun; 2(3):163-9. PubMed ID: 12099190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRCA 1/2-negative patients who receive counseling after genetic testing have lower anxiety.
    Printz C
    Cancer; 2016 Apr; 122(8):1149. PubMed ID: 27061519
    [No Abstract]   [Full Text] [Related]  

  • 13. Psychological distress in women seeking genetic counseling for breast-ovarian cancer risk: the contributions of personality and appraisal.
    Audrain J; Schwartz MD; Lerman C; Hughes C; Peshkin BN; Biesecker B
    Ann Behav Med; 1997; 19(4):370-7. PubMed ID: 9706364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic testing for breast and ovarian cancer: ethical, legal, and psychosocial considerations.
    Lessick M
    Nurs Womens Health; 2007 Aug; 11(4):390-9; quiz 400-1. PubMed ID: 17883756
    [No Abstract]   [Full Text] [Related]  

  • 15. Genetic testing for breast and ovarian cancer risk: the psychosocial issues.
    Pasacreta JV; Jacobs L; Cataldo JK
    Am J Nurs; 2002 Dec; 102(12):40-7; quiz 48. PubMed ID: 12473929
    [No Abstract]   [Full Text] [Related]  

  • 16. Knowledge and expectations of women undergoing cancer genetic risk assessment: a qualitative analysis of free-text questionnaire comments.
    Phelps C; Wood F; Bennett P; Brain K; Gray J
    J Genet Couns; 2007 Aug; 16(4):505-14. PubMed ID: 17318449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical implications of genetic testing for inherited breast and ovarian cancer risk.
    Calzone KA
    Nurs Spectr (Wash D C); 1998 Nov; 8(23):12-4. PubMed ID: 10542772
    [No Abstract]   [Full Text] [Related]  

  • 18. The counselees' self-reported request for psychological help in genetic counseling for hereditary breast/ovarian cancer: not only psychopathology matters.
    Vos J; van Asperen CJ; Oosterwijk JC; Menko FH; Collee MJ; Gomez Garcia E; Tibben A
    Psychooncology; 2013 Apr; 22(4):902-10. PubMed ID: 22740372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychosocial issues associated with increased breast and ovarian cancer risk: findings from focus groups.
    Pasacreta JV
    Arch Psychiatr Nurs; 1999 Jun; 13(3):127-36. PubMed ID: 10389341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of proband mediated information dissemination in families with a BRCA1/2 gene mutation.
    Sermijn E; Goelen G; Teugels E; Kaufman L; Bonduelle M; Neyns B; Poppe B; De Paepe A; De Grève J
    J Med Genet; 2004 Mar; 41(3):e23. PubMed ID: 14985394
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.